Ireland
--:--IST
Recruiting Observational

Prospective Descriptive Study of Injuries Associated to Anterior Shoulder Dislocations in Patients Over 40 Years

NCT05898243 · tracked via the Priya Life Science Spain tracker
Phase
Observational
Started
2023-06-01
Last updated
2024-02-07

Condition(s) studied

Anterior Glenohumeral Dislocations

Investigational drug(s) / intervention(s)

Reduction

Reduction: An Rx will be performed before and after the reduction of the dislocation. After that, the neurovascular state will be checked and also if there is some associated injury.

Study summary

The glenohumeral joint has the highest rate of dislocation of the whole body, due to its high mobility and the special characteristics of its anatomy. It is estimated that every year between 1-2% of the population will suffer from glenohumeral dislocation. The vast majority of studies are based on young patients under the age of 40, given that at this age they have the higher incidence and at the same time, they have higher redislocation index. However, the investigators are in front of a more active population with a longer life expectancy. That is why the cases of anterior glenohumeral dislocations are increasing in people older than 40 years. Given that most studies focus on younger patients, the investigators lack knowledge about which injuries are associated with dislocation at this age and whether these influence its clinical evolution.

Eligibility

Sex
ALL
Min age
40 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * More than 40 years old * First episode of traumatic anterior gelnohumeral dislocation seen in Rx * Acceptance to be checked over 2 years * Acceptance to be submitted to TAC, NMR, EMG and Bilateral Ultrasound Exclusion Criteria: * Previous fractures in this extremity * Previous neurovascular lesions in this extremity * Other associated lesions * Cognitive alterations or dementia which prevent completing the protocols. Patients with \<14 points in Mini-mental test.

Primary outcome measure(s)

  • Characterization of associated lesions — At the three months visit including assessment of NMR/EMG/TAC/Bilateral Ultrasound

Trial sites (1)

FacilityCityRegionStatus
Hospital Parc Taulí Sabadell Barcelona Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05898243 on ClinicalTrials.gov ↗ ← All trials in Spain